American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • Urge Your Members of Congress to Support Medical Research Funding

    Congress has turned its attention to the FY 2017 budget process following the release of the Obama Administration’s proposed budget in February. Though the President’s proposal seeks $33.1 billion overall for NIH, a 2.5 percent increase over FY 2016, much of the sought increase would be in the form of mandatory funding earmarked for specific projects such as the National Cancer Moonshot being led by Vice President Biden, leaving the base budget for NIH at FY 2016 levels. And, although NIH received a substantial increase in funding for the current fiscal year, lawmakers need to recognize the value of biomedical research by maintaining the investment in the NIH.

  • ASH is Working with State Level Coalitions to Pass Oral Chemotherapy Parity Legislation

    Over 40 states have already passed cancer drug coverage parity legislation and ASH is now working with three additional state level coalitions to ensure that patients in these states also have equitable coverage for oral and IV anti-cancer treatments.

View all action alerts
View all policy news
back to top